DDW Teachings Learnings

Naltrexone in AUD and liver disease: 🥇Should be 1st line 🔹Start: 50 mg daily, also available as monthly subcutaneous 🔹Use freely in Child’s A/B, ⚠️ in C but benefits will probably outweigh the theoretical risks as 🍸is ☠️for liver

Naltrexone in AUD and liver disease:

🥇Should be 1st line

🔹Start: 50 mg daily, also available as monthly subcutaneous

🔹Use freely in Child’s A/B, ⚠️ in C but benefits will probably outweigh the theoretical risks as 🍸is ☠️for liver#AGAGastroSquad @AASLDtweets @DDWMeeting pic.twitter.com/xCdRxmUtxN
— Hanna Blaney, MD, MPH (@BlaneyMD) May 20, 2024

Excellent talk on weight loss in MASLD

🥗🏃🏻‍♀️matters but typically results in a small about of weight loss (3-4%)

Incretins agonists have a big role, get comfortable prescribing!#AGAGastroSquad #livertwitter #GITwitter @DDWMeeting pic.twitter.com/VdeQ0VRd7h
— Hanna Blaney, MD, MPH (@BlaneyMD) May 20, 2024